You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. USANA HEALTH SCIENCES INC

Usana Health Sciences Inc XNYS: USNA

Usana Health Sciences Inc Live Share Price Today, Share Analysis and Chart

Value Trap
Download real time

24.24 0.41 (1.72%)

New 52W Low in past week

224.6K XNYS Volume

XNYS 22 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Usana Health Sciences Inc is on 01 May 2025 for the purpose of Usana Health Sciences Inc First Quarter Earnings Conference Call for 2025 See details

Usana Health Sciences Inc Key Metrics

Select

Market Capitalization

Below industry Median
457.2

PE TTM

Below industry Median
10.9

PEG TTM

Negative PEG TTM
-0.3

Price to Book

Below industry Median
0.9

Institutional holding current Qtr %

High in industry
57

Revenue Growth Qtr YoY %

Negative Revenue Growth Qtr YoY %
-3.4

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-7.2

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-73.3

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-34.1

Operating Profit Margin Qtr %

Below industry Median
3.8

Operating Profit Margin TTM %

High in industry
7.8

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-28.9

ROE Annual %

Below industry Median
8.2

RoA Annual %

Below industry Median
6.1
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Affordable Valuation
63.5 / 100
Momentum Score
Technically Bearish
34.7 / 100
Value Trap These stocks are with poor quality and weak financial aspects, with weak momentum. Good valuation may attract more investors as they are affordably priced. View Similar Embed DVM
Analyst Price Target
61
1Yr Price target upside is 152%
1 analysts

11

S

17

W

4

O

2

T

SWOT Analysis

Usana Health Sciences Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2680090010001100Actual RevenueAvg. Estimate
Hit

Usana Health Sciences Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
2.2
Avg. Estimate
1.7
Low Estimate
1.7
High Estimate
1.7
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 22.4% in FY25

Consensus Recommendation

0 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Usana Health Sciences Inc Stock Analysis

Usana Health Sciences Inc stock analysis with key metrics, changes, and trends.

Usana Health Sciences Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$854.5 M7.22%negative

Annual Revenue fell 7.22%, in the last year to $854.5 M. Its sector's average revenue growth for the last fiscal year was 7.49%.

Annual Net Profit$42.06 M34.06%negative

Annual Net Profit fell 34.06% in the last year to $42.06 M. Its sector's average net profit growth for the last fiscal year was -32.44%.

Price to Earning Ratio10.87-negative

Price to Earning Ratio is 10.87, higher than its sector PE ratio of 3.27.

Stock Price$24.24-45.07%negative

Stock Price fell 45.07% and underperformed its sector by 54.22% in the past year.

Quarterly Revenue$213.61 M3.38%negative

Quarterly Revenue fell 3.38% YoY to $213.61 M. Its sector's average revenue growth YoY for the quarter was 5.79%.

Quarterly Net profit$4.48 M73.26%negative

Quarterly Net profit fell 73.26% YoY to $4.48 M. Its sector's average net profit growth YoY for the quarter was -41.97%.

Debt to Equity Ratio0.05-positive

Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)8.17 %8.17%negative

Return on Equity(ROE) for the last financial year was 8.17%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding35.65 %-2.72%negative

Mutual Fund Holding decreased by 2.72% in the last quarter to 35.65.

Promoter Share Holding5.56 %0.23%positive

Promoter Share Holding increased by 0.23% in the most recent quarter to 5.56%.

Interest Coverage Ratio272.71-positive

Interest Coverage Ratio is 272.71, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding57.01 %-0.03%negative

Institutional Holding decreased by 0.03% in the last quarter to 57.01.

VIEW LESS


Loading data..

Usana Health Sciences Inc - Company Profile

What does Usana Health Sciences Inc do?

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Usana Health Sciences Inc Management structure

All Gross Remunerations are in USD
Mr. Jim H. Brown
President and Chief Executive Officer
3.36 M
2024
Gross Remuneration
Year
Mr. G. Douglas Hekking
Chief Financial Officer and Principal Accounting Officer
1.44 M
2024
Gross Remuneration
Year
Mr. Walter Noot
Chief Operating Officer
1.44 M
2024
Gross Remuneration
Year
Mr. Brent L. Neidig
Chief Commercial Officer
1.3 M
2024
Gross Remuneration
Year
Mr. P. Joshua Foukas
Chief Legal Officer, General Counsel and Corporate Secretary
1.27 M
2024
Gross Remuneration
Year
Mr. Paul A. Jones
Chief People Officer
-
2024
Gross Remuneration
Year

Usana Health Sciences Inc Board of directors

All Gross Remunerations are in USD
Mr. Kevin G. Guest
Executive Chairman of the Board
1.82 M
2024
Gross Remuneration
Year
Mr. Gilbert A. Fuller
Lead Independent Director
251.63 K
2024
Gross Remuneration
Year
Mr. Frederic J. Winssinger
Independent Director
233.63 K
2024
Gross Remuneration
Year
Ms. Peggie J. Pelosi
Independent Director
231.43 K
2024
Gross Remuneration
Year
Dr. Timothy E. Wood, PhD
Independent Director
218.43 K
2024
Gross Remuneration
Year
Mr. J. Scott Nixon, C.P.A.
Independent Director
218.43 K
2024
Gross Remuneration
Year

Usana Health Sciences Inc FAQ

How is Usana Health Sciences Inc today?
Usana Health Sciences Inc today is trading in the green, and is up by 1.72% at 24.24.
Usana Health Sciences Inc is currently trading up 1.72% on an intraday basis. In the past week the stock fell -1.02%. stock has been down -29.49% in the past quarter and fell -45.07% in the past year. You can view this in the overview section.